Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_6035_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
1
Добавлен:
15.09.2026
Размер:
16 Мб
Скачать
☆
 363
by phytoestrogens may contribute to their health benets, such as reducing cancer risk
and improving bone health. However, further research is needed to fully understand the mechanisms and effects of phytoestrogens on the WNT pathway.

15.3.4 G-PROTEIN-COUPLED ESTROGEN RECEPTOR (GPER)

G-protein-coupled estrogen receptor (GPER), also known as G protein-coupled receptor 30 (GPCR), is a membrane-bound protein involved in various physiological processes (Liu et al., 2019). Similar to other GPCRs, GPER consists of seven transmembrane domains spanning the cell membrane. GPER also possesses an extracellular domain that enables it to interact with ligands such as estrogens and phytoestrogens (Babiloni-Chust et al., 2022). The mechanisms of GPER action entail complex molecular interactions and intracellular signaling pathways. When estrogen binds to GPER, it activates several intracellular signaling pathways, including calcium signaling and cyclic adenosine monophosphate production. These pathways can trigger diverse biological responses, such as changes in gene expression, cell growth, and differentiation. Recent studies indicate that GPER may also interact with other signaling pathways, such as those related to insulin signaling and inflammation, contributing to the range of physiological processes regulated by GPER (Huang et al., 2023).
Breast cancer is one of the leading causes of female cancer deaths globally, ranking
fth according to the International Agency for Research on Cancer (Xia et al., 2022). The
interaction between estrogens and ERs plays a critical role in the onset and progression of breast cancer. Adjuvant endocrine therapy has proven effective in breast cancer prevention by disrupting ligand-ER interactions in the estrogen-ER signaling pathway and reducing endogenous estrogen levels. Recent research suggests that phytoestrogens can activate
GPER/GPR30, a membrane ER (Huang et al., 2023). Therefore, exploring the mechanisms
of GPER signaling pathways could lead to the development of novel phytoestrogen-based dietary supplements for breast cancer prevention.

15.4 STRUCTURE–ACTIVITY RELATIONSHIP (SAR) OF PHYTOESTROGENS

Phytoestrogens can interact with ERs in the body , either mimicking or blocking the effects of endogenous estrogens. Several studies have investigated the estrogenic properties of phytoestrogens, revealing their weak estrogenic effects. Research utilizing the rat uterus model to assess estrogenicity has demonstrated that phytoestrogens exhibit varying affinities for ERs. However, in general, phytoestrogens display affinities at least a
thousand-fold lower than those of 17β-estradiol, as indicated by a binding constant (k
range of 1 × 10−9–1 × 10
−10
(Kuiper et al., 1998). The structure–activity relationship (SAR)
)
d
of phytoestrogens refers to the connection between the structure of these compounds and their activity as estrogenic or antiestrogenic agents (Basu and Maier, 2018). SAR studies can identify key structural features that contribute to their weak activity and guide the development of more potent and selective molecules. The SAR of phytoestrogens has been extensively studied, and phytoestrogens can be broadly categorized into four main structural classes: isoflavones, lignans, coumestans, stilbenes, and diarylheptanoids.
364 

15.4.1 ISOFLAVONES

Isoflavones are a type of organic compound belonging to the flavonoid family. They share structural similarities with flavones and flavanones but have a distinctive 3-phenyl­chromen-4-one backbone structure, known as an isoflavone skeleton (Sohn et al., 2021). In Figure 15.3, the letters A, B, and C represent the dif ferent rings of the isoflavone backbone. The A ring consists of two fused benzene rings, while the C ring contains a single benzene ring. The B ring is a heterocyclic ring, meaning it contains an atom other than carbon as part of the ring structure—in this case, an oxygen atom.
FIGURE 15.3 Diagram illustrating the composition of isoflavones and their important members, consisting of a six-membered ring (A ring) and a five-membered ring (C ring) interconnected by a heterocyclic oxygen­containing ring (B ring). (ChemDraw 20.1.1).
⏎
Isoavones are found in signicant amounts in soybeans, chickpeas, and other legumes. Red clover, in particular, contains a higher concentration of isoavones than
soybeans, ranging from 0.5% to 2.5% by dry weight, which is 2–10 times greater (Sohn et al., 2021). Phytoestrogens in natural foods are typically present as glycones, which are molecules bound to monosaccharides, disaccharides, or polysaccharides through glycoside linkages. This linkage occurs when an alcohol group reacts with an aldehyde group. Upon
ingestion, gut bacteria can hydrolyze glycones. In the case of soybeans, isoavones exist
as glycoconjugates, with approximately 80% being glucosides or analogs such as acetyl and malonyl conjugates. Hydrolysis of glycones results in the separation of a sugar moiety and an aglycone, which is the phytoestrogen component without the carbohydrate portion (Sohn et al., 2021).
In an unpublished study conducted by the author, it was found that solid-state fermenta­tion (SSF) occurs when there is little to no free water present and the substance is in a solid-state matrix, typically a natural or synthetic support. The food and pharmaceutical industries widely use SSF for the production of enzymes, organic acids, antibiotics,
and other products. SSF is also employed as a bioprocess to convert soybean isoavone
glycosides to aglycones, thereby enhancing the hydrolysis of glycoside linkages present
in isoavone glycosides that inhibit the absorption and biological activity of isoavones.
During SSF, microorganisms such as fungi or bacteria are inoculated onto a solid-state
matrix containing soybean meal, soy our, or soy protein isolate and allowed to grow and
 365
generate enzymes, such as β-glucosidase. These enzymes cleave the sugar moieties from the isoavone glycosides, leading to the formation of isoavone aglycones. The aglycones
produced during SSF exhibit higher biological activity than their glycoside counterparts, making them more desirable for food and pharmaceutical applications. Moreover, SSF is
considered an eco-friendly and cost-effective method for converting soybean isoavone
glycosides to aglycones compared with other conventional methods involving the use of strong acid solutions or higher temperatures.
Figure 15.3 illustrates some important isoavone forms of phytoestrogens. The most common isoavones present in plants are genistein and daidzein, which possess
a hydroxyl (OH) group attached to the B ring. They closely resemble the structure of
endogenous estradiol, with two aromatic rings connected by a carbon‒carbon double bond. Other prevalent isoavones include glycitein, biochanin A, formononetin, and prunetin
(Ramachandran et al., 2022). Studies have demonstrated that different substitutions and
modications to the basic isoavone structure can signicantly impact their binding afnity to ERs, as well as their potency and selectivity as estrogen agonists or antagonists. For instance, the substitution of hydroxyl groups at different positions on the isoavone ring can inuence its binding afnity and potency. In particular, the presence of a hydroxyl group at the 4’ position on the B-ring of the isoavone appears crucial for its estrogenic
activity. Additionally, the presence of a hydroxyl group at the 7 position on the A-ring
has been shown to enhance the estrogenic activity of isoavones (Cho et al., 2021). Furthermore, the nature of the substituents in the isoavone can also impact its activity.
For example, the presence of a methoxy (–OCH3) group at position 4 on the B-ring of
isoavone has been found to increase its potency as an estrogen agonist. Conversely, the
presence of a hydroxyl group at the 5 position on the A-ring has been shown to decrease
the estrogenic activity of isoavones (Cho et al., 2021).

15.4.2 LIGNANS

Lignans represent another category of phytoestrogens that are found in flaxseeds, sesame seeds, and whole grains (Swathi Krishna et al., 2022). They possess a complex structure comprising two benzene rings connected by a butyrolactone unit, along with two side chains attached to the rings (Tanwar et al., 2021). The side chains can vary depending on the specific lignan, but they typically contain multiple methoxy groups (–OCH3) and/or hydroxyl groups (–OH) (Figure 15.4) (Baldi et al., 2023). The estrogenic activity of lignans is generally influenced by several structural features, including the number and position of hydroxyl (–OH) groups on the molecules, the presence of an aromatic ring system, and the stereochemistry of the molecule. The presence of hydroxyl groups is an important factor that affects the estrogenic activity of lignans. Lignans with more hydroxyl groups generally exhibit greater estrogenic activity, likely due to their capability to form hydrogen bonds with ERs in the body (López-Rojas et al., 2022).
Enterolactone and enterodiol are two lignans that exhibit potent estrogenic activity attributed to their multiple hydroxyl groups (Baldi et al., 2023). The position of hydroxyl groups on the lignan molecule also plays a role in determining its estrogenic activity.
366 
Lignans with hydroxyl groups in specic positions, such as the 7-hydroxyl group in secoisolariciresinol from axseeds, have demonstrated higher estrogenic activity than those
lacking such groups. Alongside hydroxyl groups, the presence of an aromatic ring system within the lignan molecule is crucial for its estrogenic activity. The aromatic ring system
can interact with ERs, inuencing their activity. For instance, matairesinol from axseeds,
which incorporates an aromatic ring system, exhibits strong estrogenic activity . Hence, the stereochemistry of the lignan molecule can also impact its estrogenic activity . Lignans can exist in various stereoisomeric forms, each possessing distinct three-dimensional structures (López-Rojas et al., 2022).
FIGURE 15.4 (a) The backbone structure of lignans consists of two phenylpropane units linked together by
a β–β′ bond, forming a bicyclic system known as a dibenzylbutane skeleton (a). Some examples of lignans that
exhibit phytoestrogen properties: matairesinol (b), secoisolariciresinol (c), arctigenin (d), enterolactone (e), and enterodiol (f). (ChemDraw 20.1.1).
⏎
López-Rojas et al. (2022) studied the estrogenic and antiestrogenic qualities of lignan
derivatives derived from natural dibenzylbutyrolactones. Compared to 17β-estradiol,
 367
these compounds had lower potency in triggering ERE-driven reporter gene expression
but reduced the potency and efcacy of pure agonists when combined with 17β-estradiol. Binding assays conrmed the attachment of the lignan derivatives to rhERα-LBD, with
IC50 values between 0.16 μM (compound 14) and 6 μM (compound 4). For compound 14, its binding mode interactions were further analyzed through docking and molecular simulations. In silico predictions showed that the potent lignan derivatives had favorable drug-like attributes. The study highlighted compound 14’s potential as a treatment for hormone-dependent cancers and emphasized the need for further research on these compounds in ER-dependent diseases.

15.4.3 COUMESTANS

The classification of coumestrol as a phytoestrogen was based on its isolation by Bickoff et al. (1957) from alfalfa, ladino clover, and strawberry clover , all belonging to the Fabaceae family (Trifolium r epens L., Medicago sativa L., and T rifolium fragiferum L., respectively) (Melo et al., 2010). While legumes are primarily where coumestrol is found in diets, traces of it can also be spotted in vegetables such as Brussels sprouts and spinach. Clover and soybean sprouts are noted to have the richest content of coumestrol among all sources. Coumestans have a structure similar to that of isoflavones but with a five-membered ring instead of a six-membered ring (Tu et al., 2021). The backbone structure of coumestans consists of a benzopyran ring system fused to a benzene ring. The benzopyran ring system contains a six-membered oxygen-containing ring (known as a pyran ring) fused to a benzene ring. In coumestans, the benzopyran ring system is further substituted with various functional groups, such as hydroxyl (–OH), methyl (–CH3), or methoxy (–OCH3) groups, which can affect their biological activity (Figure 15.5). For example, the presence of hydroxyl groups on the coumestan backbone allows them to bind to ERs in the body and exhibit estrogenic activity (Jameera Begam et al., 2017).
FIGURE 15.5 The backbone structure of coumestans consists of a benzopyran ring system, with a hydroxyl group at position 7 and a second aromatic ring attached at position 3. (ChemDraw 20.1.1).
⏎
The SAR of coumestans is complex and involves multiple structural features that contribute to their estrogenic activity. Here are some key aspects of the SAR of phytoes­trogen coumestans. (1) Coumestans contain a coumarin moiety, which is essential for their estrogenic activity. This moiety consists of a benzene ring fused to a pyrone ring.
368 
The position of substituents on the benzene ring and the nature of the substituents can affect the estrogenic activity of coumestans. (2) The presence of hydroxyl groups in the coumarin moiety is important for estrogenic activity. The number and position of hydroxyl groups can affect the potency of coumestans as estrogen agonists or antagonists. (3) The substitu­tion pattern of the B-ring of coumestans is also important for their estrogenic activity. In general, hydroxyl or methoxy groups at the 6-position of the B-ring enhance estrogenic activity, while substitutions at the 3-position reduce estrogenic activity. (4) The presence of a prenyl group on coumestans can enhance their estrogenic activity. Prenylation refers to the addition of an isoprene unit to a molecule. Coumestans with a prenyl group at the
4′-position of the B-ring are more potent estrogen agonists than those without a prenyl
group (Bhavnani et al., 2008). (5) The stereochemistry of coumestans can also affect their estrogenic activity. In general, the S-conguration at the 3′-position of the prenyl group is more favorable for estrogenic activity than the R-conguration.
Puerariacandollei and P. candollei var. mirica are plants native to Thailand and are commonly used in traditional medicine (Warinsiriruk et al., 2022). The tuberous roots of these plants contain several phytoestrogens, including miroestrol, deoxymiroestrol, and isomiroestrol (Figure 15.6), which have been shown to have the strongest estrogenic activity among the compounds found in the plant (Juengsanguanpornsuk et al., 2021). These compounds can bind to ERs in the body and have been shown to help alleviate
menopause symptoms such as mood swings, vaginal dryness, and hot ashes. In addition
to deoxymiroestrol and miroestrol, Pueraria candollei var. mirica also contains other phytoestrogens, such as genistein, daidzein, and coumestrol, which have been shown to have weaker estrogenic effects than miroestrol and deoxymiroestrol. Puerariacandollei var. mirica is commonly used in supplements and creams for menopause symptoms, as well as for breast enlargement. However, additional studies are required to comprehensively grasp the impacts of this plant on the body and any possible adverse reactions.
FIGURE 15.6 Chemical structures of the prominent coumestans found in P. candollei and P. candollei var. mirifica roots: miroestrol, deoxymiroestrol, and isomiroestrol. (ChemDraw 20.1.1).
⏎
Coumestrol exhibits potential therapeutic properties against the development and advancement of human skin cancer cells. It triggers apoptosis via the mitochondria, halts
the cell cycle, inhibits cell migration and invasion, and inuences the m-TOR-/PI3K/AKT
signaling pathway. These mechanisms suggest that coumestrol has potential as an anti­cancer agent for skin cancer. However, preclinical in vivo studies are required to identify
 369
its toxicity, pharmacokinetics, and bioavailability before it can be used as a lead drug in curbing skin cancer (Kuang et al., 2021).

15.4.4 STILBENES

Stilbene phytoestrogens are compounds naturally present in several plants, such as grapes, berries, peanuts, and soybeans. Their defining feature is a central structure made of two benzene rings linked by a double bond. The estrogenic activity of stilbenes arises from their
structural similarity to 17β-estradiol. The presence of hydroxyl (–OH) groups at specific
positions in the stilbene structure is considered crucial for their estrogenic activity. These hydroxyl groups enable hydrogen bonding and other interactions with ERs, facilitating binding and activation of the receptors.
Stilbenes have garnered signicant attention due to their potential health benets. Research has explored their possible signicance in hormone-associated issues, including menopausal symptoms, bone loss conditions such as osteoporosis, and specic cancer
forms. Their estrogenic activity can support the body’s hormonal balance and may have therapeutic implications. It is worth noting that the estrogenic effects of stilbenes can
vary depending on the specic compounds and their concentration. Some stilbenes may
act as estrogenic agonists, mimicking the effects of estrogen, while others may exhibit antagonistic properties, blocking or inhibiting ERs.
For instance, resveratrol (Figure 15.7) is a polyphenolic compound found in sources such as grapes, berries, and peanuts. While resveratrol exhibits potent anticancer properties, it does have some drawbacks attributed to its unstable double bond, rapid metabolism, and short half-life, which render it susceptible to photoisomerization. To address these limitations, researchers have explored the potential advantages of using the stable and nontoxic form, trans-(E)-resveratrol. However, the biological and pharmacological activities of the photoisomerized form, cis-(Z)-resveratrol, remain poorly understood (Jang et al., 2022).
FIGURE 15.7 Chemical structure of trans-resveratrol. (ChemDraw 20.1.1).
⏎
370 
Recently , Kobylka et al. (2022) studied the SAR of 1 1 resveratrol analogs to understand their impact on the estrogen signaling pathway . These analogs, which included combinations of methoxy groups and hydroxylated versions, were tested on ERs and estrogen-dependent cells. The research revealed that these analogs can be both agonists and antagonists of
ERs. Specically, 3,4,4′5′-tetrahydroxystilbene and a few others might act as selective
modulators of these receptors. The study highlighted the dose-dependent activity of these analogs and their potential therapeutic value for conditions such as breast cancer and osteoporosis, paving the way for potential new treatments based on these compounds.

15.4.5 DIARYLHEPTANOIDS

The chemistry of diarylheptanoids involves a central seven-carbon (heptane) core struc­ture with two aromatic (aryl) rings attached to it. The core structure typically consists of a chain of carbon atoms with various substituents, such as hydroxyl groups (–OH) and methoxy groups (–OCH
), attached at different positions. The specific arrangement and
3
substitution pattern of these aryl rings and functional groups contribute to the diversity and biological activity of diarylheptanoids. The biosynthesis of diarylheptanoids involves multiple enzymatic steps within plants. The key precursor for diarylheptanoid synthesis is usually a molecule called phenylpropanoid, which is derived from the shikimate pathway. Enzymatic processes such as hydroxylation, methylation, and glycosylation can alter phenylpropanoids, resulting in the creation of diarylheptanoids with varied structures and characteristics.
Regarding the diarylheptanoid phytoestrogens present in C. comosa rhizomes, these substances have attracted interest for their potential health advantages, especially concerning their estrogenic properties (Thongon et al., 2017; Yingngam et al., 2021; Limpongsa et al.,
2023). Figure 15.8 represents the basic structure of diarylheptanoids, which comprises a seven-carbon chain with two aromatic rings located at the ends (Yingngam et al., 2018). Here, “Ar” represents an aryl group, which is a type of organic molecule that contains an aromatic ring. The two aryl groups in a diarylheptanoid can be the same or different, and they can be attached to the seven-carbon chain at various positions. The specic arrange­ment of atoms and bonds in the backbone of each diarylheptanoid molecule can vary depending on the plant species and other factors. However, the overall structure of these compounds tends to be relatively rigid, which allows them to interact with ERs in the body and mimic the effects of natural estrogens (Tipbunjong et al., 2017).
Different modications to this basic structure can lead to changes in their biological activity. For example, the presence of hydroxyl groups at specic positions on the aromatic
rings can increase their estrogenic activity. Several SAR studies have been conducted
on these compounds, and they have identied some important structural features that
are responsible for their estrogenic activity. For instance, having a phenolic hydroxyl group at the 3′ and 4′ positions of the aromatic ring results in increased estrogenic
activity. Enhancing the activity of diarylheptanoid analogs can benet from introducing a
hydroxyl group on the aromatic ring, which can further be altered with isosteric groups.
Additionally, the reduced polarity of the second phenyl ring allows for a better t within
 371
the hydrophobic cavity of the ERβ receptor (Jongkon and Tangyuenyongwatana, 2014).
Likewise, a methoxy group at the 3 position of the alternate aromatic ring can boost their
efcacy. Other modications, such as the length of the carbon chain or the substitution
pattern on the aromatic rings, can also affect their activity. For example, for the phenyl ring to effectively conform to the receptor-binding pocket, diarylheptanoids rely on the
inherent exibility of the heptyl chain, while substitutions on the aromatic rings can lead to changes in their binding afnity for ERs (Winuthayanon et al., 2009; Jongkon and
Tangyuenyongwatana, 2014; Tipbunjong et al., 2017).
FIGURE 15.8 Photograph of Curcuma comosa Roxb. and the chemical structures of three compounds: (a) compound 1, which is 1-(3,4-dihydroxyphenyl)-7-phenyl-(6E)-6-heptan-3-ol, (b) compound 2, which is (4E,6E)-1,7-diphenylhepta-4,6-dien-3-ol, and (c) compound 3, which is (6E)-1,7-dipheylhept-6-en-3-ol.
⏎
In summary, the SAR of phytoestrogens is complex and involves the presence and position of hydroxyl groups on the molecule, as well as the structure of the compound itself. Understanding the SAR of phytoestrogens can help in the design of new compounds with improved estrogenic or antiestrogenic activity to address conditions such as osteoporosis, breast malignancies, and cardiovascular diseases.

15.5 COMPARING POTENCY AND EFFICACY OF PHYTOESTROGENS ON VARIOUS PATHWAYS

According to the literature, the potency of phytoestrogens has been evaluated using various test methods, including bioassays, in vitro receptor-binding studies, and clinical assays (Juengsanguanpornsuk et al., 2021; Kornhuber et al., 2021). Nevertheless, estimating estrogen potency is complex due to various test-related variables, such as animal choice,
372 
target organ response, dosage, timing, and drug delivery method. Furthermore, extrapolating
data from animals to humans adds complexity. From these tests, 17β-estradiol is seen as the most potent estrogen. Estrone is approximately 50–70% less active than 17β-estradiol,
while estriol is the least potent, at only one-tenth the potency of estradiol. T ransformations of these estrogens usually yield inactive products (Das et al., 2022).
The rodent uterotrophic assay is widely utilized in vivo test to assess the estrogenic potency and mechanisms of action of phytoestrogens. Various protocols have been devel­oped involving the use of immature, hypophysectomized, or ovariectomized rats and mice and the administration of the test substance either orally or subcutaneously. However, the author believes that evaluating the stimulation of uterine growth caused by a compound or
a plant extract alone is insufcient to fully characterize its estrogenicity.
Loutchanwoot et al. (2016) studied the estrogenic potency of puerarin, found in Pueraria lobata and P. candollei var. mirica, on pituitary function in female rats. The research focused on its effects on plasma prolactin, growth hormone levels, and estrogen-regulated genes in the pituitary, comparing puerarin to a known ER agonist over 12 weeks. Puerarin showed weak
estrogen-like activities, inuencing the ERβ and TERP-1/-2 pathways and leading to altered mRNA expression and growth hormone levels. These ndings provide initial evidence of
puerarin’s subtle estrogenic effects on the pituitary in ovariectomized rats.

15.5.1 POTENCY AND EFFICACY OF PHYTOESTROGENS ON DIFFERENT PATHWAYS

Phytoestrogens have been studied for their potential health benefits, particularly for women’ s health. Comparing the potency and efficacy of phytoestrogens on different pathways, it is important to note that different phytoestrogens have varying levels of potency and activity on different ERs and pathways in the body. Here are some key points to consider. (1)
Phytoestrogens can bind to both ERα and ERβ (Sim et al., 2022). The potency and efficacy
of phytoestrogens on these receptors can vary depending on the specific compound. (2) Some phytoestrogens, such as genistein and daidzein found in soy products, have been
found to have a higher affinity for ERβ than ERα. The potential health advantages of this could be significant, given that ERβ is believed to offer protection against specific cancers,
including breast and prostate cancer (Ahlin et al., 2023). (3) In addition to their effects on ERs, phytoestrogens can also have other effects on the body, such as antioxidant and anti-inflammatory effects (Yen et al., 2023). The potency and efficacy of these effects may also vary depending on the specific compound. Thus, the potency and efficacy of phytoestrogens on different pathways can vary depending on the specific molecule and the receptor or pathway being targeted.
For example, Procházková et al. (2017) studied phytoestrogens and sterols in water
samples with abundant cyanobacteria. They developed methods to analyze eight avonoids and ve sterols. Flavonoid concentrations varied, with some being undetectable, while sterols reached up to 2.25 μg/l. Using an in vitro assay, coumestrol was identied as the
most potent phytoestrogen. However, only 8.5% of the estrogenic activity in the water came from phytoestrogens, hinting that other compounds, possibly human-made steroid estrogens, contributed more to the estrogenic effects in these waters.